Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02677532
Other study ID # APERIVIP
Secondary ID
Status Completed
Phase Phase 4
First received January 29, 2016
Last updated February 8, 2016
Start date December 2011
Est. completion date January 2014

Study information

Verified date February 2016
Source University of Genova
Contact n/a
Is FDA regulated No
Health authority Italy: Ethics Committee
Study type Interventional

Clinical Trial Summary

The aim of the study is to determine wether continuous wound infusion with local anaesthetic plus a single dose intravenous morphine is non-inferior to postoperative analgesia provided with continuous thoracic epidural infusion of local anaesthetic plus opiate, in patients undergoing open abdominal aortic aneurism repair.


Recruitment information / eligibility

Status Completed
Enrollment 51
Est. completion date January 2014
Est. primary completion date November 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Scheduled for elective open aortic aneurism repair

Exclusion Criteria:

- Patient refusal

- Platelet count < 80*10^3/mcL

- International Normalised Ratio > 1.5

- Other contraindications to the placement of epidural catheter, including ongoing anti platelet or anticoagulant treatment not suspended according to national guidelines

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Paracetamol
1 g every 8 hours
Levobupivacaine wound infiltration
Wound infiltration with 10 ml levobupivacaine 0.5%
Levobupivacaine epidural bolus
Epidural bolus of 10 ml 0.25% levobupivacaine
Sufentanil epidural bolus
Epidural bolus of 0.15 mcg/kg sufentanil
Morphine
Intravenous slow bolus of 10 mg morphine
Device:
Epidural catheter placement
Thoracic epidural catheter placement in the T7-T8 or T8-T9 intervertebral space
Wound infusion catheters placement
Pre-peritoneal placement of two catheters for wound infusion
Drug:
Levobupivacaine plus sufentanil epidural infusion
Epidural infusion of levobupivacaine 0.12% plus sufentanil 0.4 mcg/ml at 4 ml/h for 48 h
Levobupivacaine wound infusion
Wound infusion with levobupivacaine 0.25% at 4 ml/h for 48 h

Locations

Country Name City State
Italy UO Anestesia e Terapia Intensiva, IRCCS AOU San-Martino IST Genova

Sponsors (1)

Lead Sponsor Collaborator
University of Genova

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Other Incidence of postoperative cardiovascular adverse events Intra-hospital follow-up of up to 3 months after surgery Yes
Other Incidence of postoperative pulmonary complications Intra-hospital follow-up of up to 3 months after surgery Yes
Primary Average postoperative pain assessed with numeric rating scale (NRS) in the first 48 hours Average of the NRS recorded at the different time-points (up to 48 hours after emergence from general anaesthesia) No
Secondary Need for rescue doses of morphine at each time-point Need for a bolus of 5 mg intravenous morphine to relief pain 0, 4, 8, 12, 24, 36, 48 hours after emergence from general anaesthesia No
Secondary Number of patients requiring oxygen administration at each time-point 0, 4, 8, 12, 24, 36, 48 hours after emergence from general anaesthesia No
Secondary Number of patients that have restored bowel function at each time-point Time to first stool analysis 0, 4, 8, 12, 24, 36, 48 hours after emergence from general anaesthesia No
Secondary Number of patients whose urinary catheter was removed at each time-point Time to catheter removal analysis 0, 4, 8, 12, 24, 36, 48 hours after emergence from general anaesthesia No
Secondary Number of patients that have restored ability to walk at each time-point 0, 4, 8, 12, 24, 36, 48 hours after emergence from general anaesthesia No
Secondary Non-invasive blood pressure (mmHg) at each time-point Blood pressure (systolic, diastolic, mean in mmHg) 0, 4, 8, 12, 24, 36, 48 hours after emergence from general anaesthesia Yes
Secondary Length of hospital stay Follow-up of up to 3 months after surgery No
Secondary Heart rate (bpm) at each time-point 0, 4, 8, 12, 24, 36, 48 hours after emergence from general anaesthesia No
Secondary Incidence of postoperative nausea and vomiting 0, 4, 8, 12, 24, 36, 48 hours after emergence from general anaesthesia No
See also
  Status Clinical Trial Phase
Completed NCT04633850 - Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
Recruiting NCT03181620 - Sedation Administration Timing: Intermittent Dosing Reduces Time to Extubation N/A
Completed NCT04579354 - Virtual Reality (VR) Tour to Reduce Preoperative Anxiety Before Anaesthesia N/A
Recruiting NCT06007378 - Optimizing Postoperative Pain Control After Laparoscopic Colorectal Surgery N/A
Recruiting NCT05943015 - Analgesic Efficacy of Quadratus Lumborum, Paravertebral Blocks N/A
Completed NCT04544228 - Ketamine or Neostigmine for Serratus Anterior Plane Block in Modified Radical Mastectomy N/A
Completed NCT03678168 - A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries N/A
Completed NCT03286543 - Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System N/A
Completed NCT03663478 - Continuous TQL Block for Elective Cesarean Section Phase 4
Completed NCT04176822 - Designing Animated Movie for Preoperative Period N/A
Completed NCT05170477 - Influence of Apical Patency Concept Upon Postoperative Pain After Root Canal Treatment N/A
Completed NCT06425601 - A Comparison of Silicone Versus Polyvinylchloride (PVC) Drains Following VATS Lobectomy N/A
Not yet recruiting NCT04561856 - Fascia Iliaca Block Supplemented With Perineural Vs Intravenous Dexamethasone Phase 4
Completed NCT03612947 - TAP Block in Laparoscopic Cholecystectomy. Phase 2
Completed NCT05974501 - Pre vs Post Block in Total Knee Arthroplasty (TKA) Phase 4
Completed NCT05995912 - Efficacy and Safety of Etoricoxib-tramadol Tablet in Acute Postoperative Pain Phase 2
Completed NCT04571515 - Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain Phase 2
Active, not recruiting NCT04190355 - The Effect of Irrigant Types Used During Endodontic Treatment on Postoperative Pain N/A
Recruiting NCT05145153 - Incidence of Chronic Pain After Thoracic Surgery
Recruiting NCT03697278 - Monitoring Postoperative Patient-controlled Analgesia (PCA) N/A